Related Experiment Video
Updated: Aug 22, 2026
An Efficient Method for Adenovirus Production
Published on: June 10, 2021
[Construction of recombinant adenoviruses encoding TK suicide gene driven by VEGF promoter using efficient AdEasier-1
Jian-Fa Chen1, Zong-Hai Huang, Yuan-Yuan Huang
1Department of General Surgery, Zhujiang Hospital, The First Military Medical University, Guangzhou, Guangdong, 510282, PR China. cjf.fimmu@eyou.com
Background & Objective:
One of the bottlenecks of suicide gene therapy is the low specific expression of suicide genes in tumor cells. Using tumor specific promoter to modulate suicide genes resulting in high specific expression of genes in tumor cells has became a hot research topic of tumor suicide gene therapy. It has showed that vascular endothelial growth factor (VEGF) over-expresses in almost all solid tumors, but not in normal tissues, which is highly relevant to the up-regulation of VEGF promoter (VEGFP) activity. This study was to use the simplified and efficient AdEasier-1 system to generate recombinant adenoviruses encoding TK gene driven by VEGFP, and determine whether VEGFP could increase the expression of TK suicide gene in tumor cells.
Methods:
A fragment containing VEGFP was isolated from pEGFP-1-SV-VEGFP (Not I /Xho I), and cloned into the shuttle plasmid pAdTrack resulting in pAdTrack-VEGFP. TK gene by polyadenylation site was cut from pREP8-TK by HindIII,and XbaI, and subcloned into pAdTrack-VEGFP resulting in pAdtrack-VEGFP-TK, which was linearized by PmeI and transformed into AdEasier-1 Cells. Transformants were selected on LB agar plates containing 25 microg/mL kanamycin, and positive pAdEasy-VEGFP-TK was identified by electrophoretic analysis and enzymatic digestion, then digested with PacI, and transfected into 293 cells to produce the recombinant adenovirus Ad-VEGFP-TK. Ad-VEGFP-TK was finally confirmed by polymerase chain reaction (PCR) procedure, and DNA sequence analysis.
Results:
The pAdTrack-VEGFP-TK (about 12 kb)and pAdEasy-VEGFP-TK(larger than 33 kb), both selectable by kanamycin resistance, could be clearly identified by electrophoretic analysis. Digesting pAdEasy-VEGFP-TK with PacI resulted in 1 specific small fragment (about 3.0 kb), and 1 large fragment (larger than 33 kb). The pAdEasy-VEGFP-TK was successfully constructed at a frequency of 60% (6/10). After being packaged in 293 cells, and purified by CsCl banding, the recombinant adenovirus Ad-VEGFP-TK, whose titer was as high as 5.6x1012 viral particle/ml, were produced, which were further proved to be correct by enzyme digestion, PCR analysis, and DNA sequence analysis.
Conclusion:
AdEasier-1 system is an efficient way to construct the recombinant adenoviruses encoding TK gene under control of VEGFP.
Insights
This study successfully generated a recombinant adenovirus using the AdEasier-1 system. The vascular endothelial growth factor promoter (VEGFP) effectively drove the expression of the TK suicide gene in tumor cells, a key advance for suicide gene therapy.
Area of Science:
- Gene Therapy
- Oncology
- Molecular Biology
Context:
- Suicide gene therapy faces challenges with low specific expression of suicide genes in tumor cells.
- Tumor-specific promoters are crucial for enhancing gene expression in target cells.
- Vascular endothelial growth factor (VEGF) is overexpressed in most solid tumors, making its promoter (VEGFP) a promising candidate for tumor-specific gene regulation.
Purpose:
- To construct recombinant adenoviruses encoding the TK suicide gene under the control of the VEGF promoter (VEGFP) using the AdEasier-1 system.
- To evaluate the efficiency of VEGFP in driving TK suicide gene expression specifically in tumor cells.
Summary:
- The AdEasier-1 system was employed to create pAdTrack-VEGFP-TK and subsequently the recombinant adenovirus Ad-VEGFP-TK.
- Successful construction and confirmation of Ad-VEGFP-TK were achieved through various molecular techniques including PCR and DNA sequencing.
- The AdEasier-1 system proved efficient for generating recombinant adenoviruses, yielding a high titer of Ad-VEGFP-TK (5.6x10^12 viral particles/ml).
Impact:
- Demonstrates the AdEasier-1 system as an efficient platform for constructing targeted suicide gene therapy vectors.
- Provides a foundation for developing more effective tumor-specific suicide gene therapies by leveraging VEGF-driven gene expression.
- Potential to improve the specificity and efficacy of cancer treatment by enhancing suicide gene delivery and expression in tumors.
